Back to calendar
Regeneron Pharmaceuticals, Inc. (REGN) Earnings
REGN reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026 · Before Market Open
Est. EPS: $15.90
Actual EPS: $14.29
EPS surprise: 40.69%
Company overview
Market Cap$82.1B
PriceUSD 797.78
P/E19.72
EPS (TTM)40.46
52-week high821.11
52-week low541.00
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees15,410